Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7 | 1 | N/A | N/A | N/A |
| Receivables | 30 | 5 | N/A | N/A | N/A |
| Other current assets | 13 | 394 | 0 | 0 | 0 |
| TOTAL | $50 | $400 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $220 | $570 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 160 | 310 | 0 | 0 | 0 |
| Accrued Expenses | 100 | 60 | N/A | N/A | N/A |
| TOTAL | $280 | $650 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 80 | 0 | N/A | N/A | N/A |
| TOTAL | $80 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $360 | $650 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 440 | 430 | N/A | N/A | N/A |
| Retained earnings | -3,120 | -2,120 | N/A | N/A | N/A |
| Other shareholders' equity | 10 | 10 | 0 | 0 | 0 |
| TOTAL | $-140 | $-70 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $220 | $580 | $0 | $0 | $0 |